Bayer Reaches Deals on Big Share of 125,000 Roundup Weedkiller Suits
- Agreements part of $10 billion company plan to end all claims
- Bayer under pressure since acquiring Roundup in Monsanto deal
This article is for subscribers only.
Bayer AG has reached verbal agreements to resolve a substantial portion of an estimated 125,000 U.S. cancer lawsuits over use of its Roundup weedkiller, according to people familiar with the negotiations.
The deals, which have yet to be signed and cover an estimated 50,000 to 85,000 suits, are part of a $10 billion Bayer plan to end a costly legal battle the company inherited when it acquired Monsanto in 2018, the people said. While some lawyers are still holding out, payouts for settled cases will range from a few million dollars to a few thousand each, said the people, who asked not to be identified because they aren’t authorized to speak publicly.